STAT3 and pulmonary arterial hypertension: Another limitation was our inability to detect alterations in key PAH-associated proteins, such as bone morphogenetic protein receptor type II (BMPR2), STAT3, and phosphor-STAT3 (Balistrieri et al., 2023).